Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

KORU Medical Systems (KRMD) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to 8.34%.

  • KORU Medical Systems' EBITDA Margin rose 97000.0% to 8.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.28%, marking a year-over-year increase of 97100.0%. This contributed to the annual value of 19.16% for FY2024, which is 168500.0% up from last year.
  • KORU Medical Systems' EBITDA Margin amounted to 8.34% in Q3 2025, which was up 97000.0% from 3.07% recorded in Q2 2025.
  • KORU Medical Systems' EBITDA Margin's 5-year high stood at 3.07% during Q2 2025, with a 5-year trough of 53.51% in Q2 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 22.72% (2023), whereas its average is 26.19%.
  • Per our database at Business Quant, KORU Medical Systems' EBITDA Margin plummeted by -492600bps in 2021 and then soared by 318700bps in 2024.
  • KORU Medical Systems' EBITDA Margin (Quarter) stood at 32.56% in 2021, then dropped by -5bps to 34.19% in 2022, then grew by 11bps to 30.58% in 2023, then soared by 41bps to 17.98% in 2024, then skyrocketed by 54bps to 8.34% in 2025.
  • Its EBITDA Margin was 8.34% in Q3 2025, compared to 3.07% in Q2 2025 and 12.92% in Q1 2025.